Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US2022204481A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022204481-A1 |
| Application number | US-202017432838-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 28, 2020 |
| Priority date | Feb 28, 2019 |
| Publication date | Jun 30, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An object of the present invention is to provide a technique that allows other molecules/substances to be more selectively linked to the N-terminus in a simple and efficient manner, even in natural proteins etc. This object is achieved by reacting a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof with a protein and/or peptide.
Opening claim text (preview).
In the claims: 1 . A reagent for protein and/or peptide modification, comprising a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material. 2 . The reagent according to claim 1 , wherein the compound is represented by formula (1A): wherein R 4 is as defined above. 3 . The reagent according to claim 1 , wherein the organic group is a group derived from an organic molecule or an organic molecular complex, and the organic molecule or the organic molecular complex is a functional substance. 4 . The reagent according to claim 3 , wherein the functional substance is a pharmaceutical compound, a luminescent molecule, a macromolecular compound, a ligand, a molecule to which a ligand binds, an antigenic protein, an antibody, a protein, a nucleic acid, a saccharide, a lipid, a cell, a virus, a label, a carbon electrode, a carbon nanomaterial, a linker, a spacer molecule, or a complex or linked molecule thereof. 5 . The reagent according to claim 1 , wherein the inorganic material is an electrode material, metal fine particles, metal oxide fine particles, semiconductor particles, or magnetic particles. 6 - 8 . (canceled) 9 . A method for producing a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material, the method comprising: reacting a compound represented by formula (5): R 4 -R 9 (5), wherein R 4 represents an organic group or a group derived from an inorganic material; and R 9 represents —NR 9a R 9b (wherein R 9a and R 9b are the same or different and each represents a hydrogen atom or an alkyl group), with a compound represented by formula (6): wherein R 10 represents an electron-withdrawing group; R 11 represent —R 11a —R 12 (wherein R 11a represents a single bond or a linker; and R 12 represents a carrier); n represents 0 or 1; and m represents an integer of 1 to 5. 10 . A compound represented by formula (6′): wherein R 10 represents an electron-withdrawing group; R 11a represents a single bond or a linker; R 12 represents a carrier; and m represents an integer of 1 to 5. 11 . A compound represented by formula (7) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material; a double line composed of a dotted line and a solid line represents a single bond or a double bond; R 13 represents a group in which the N-terminal amino acid residue and —NH— adjacent thereto are excluded from a protein or peptide; and R 14 represents the side chain of the N-terminal amino acid residue of the protein or peptide. 12 . A method for producing the compound or a salt thereof, or a hydrate or solvate of the compound or a salt thereof according to claim 11 , the method comprising reacting a protein and/or a peptide with a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material.
the carrier being a synthetic polymer · CPC title
Production of labelled immunochemicals · CPC title
1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Ortho-condensed systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.